Description
CIFGEN AZ LB is a synergistic formulation designed to offer comprehensive treatment for bacterial infections. It combines the antibiotics Cefixime and Azithromycin, both known for their broad-spectrum activity, with Lactic Acid Bacteria (LB) to safeguard gut health during antibiotic therapy.
Cefixime (200mg): Cefixime is a third-generation cephalosporin antibiotic that is effective against a wide variety of bacterial infections, including those of the respiratory tract, urinary tract, skin, and more. It works by disrupting the bacterial cell wall, leading to bacterial cell death.
Azithromycin (250mg): Azithromycin is a macrolide antibiotic known for its broad-spectrum action against both gram-positive and gram-negative bacteria. It is commonly used to treat respiratory tract infections, skin infections, ear infections, and sexually transmitted diseases (STDs). Azithromycin works by inhibiting bacterial protein synthesis, thus preventing the growth and replication of bacteria.
Lactic Acid Bacteria (LB): The inclusion of Lactic Acid Bacteria (LB), a type of beneficial probiotic, helps restore the natural balance of the gut microbiota. Probiotics are important during antibiotic therapy to prevent disruptions to gut health, such as antibiotic-associated diarrhea, and to support overall digestive function.
CIFGEN AZ LB is an ideal choice for patients needing dual antibiotic treatment for bacterial infections while also maintaining a healthy gut microbiome. It effectively targets a broad spectrum of bacterial infections and minimizes the common gastrointestinal side effects often associated with antibiotics.
